# A Phase II Study of GC101 in NSCLC

> clinical trial · VERIFIED · 2026-08-05

Status: RECRUITING · Sponsor: Shanghai Juncell Therapeutics · Condition: Non Small Cell Lung Cancer

- Company: Shanghai Juncell Therapeutics
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT07560111

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.